Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters











Publication year range
1.
J Hum Hypertens ; 19(3): 197-203, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15565174

ABSTRACT

The performance of five units of the A&D UA-767 NIBP monitor and five units of the Welch Allyn Spot Vital Signs noninvasive blood pressure monitor was evaluated with the Biotek BP Pump blood pressure simulator under a variety of conditions. Using the simulator to provide a normal blood pressure waveform at 80 bpm over a range of pressures, it was found that the mean bias for the combined results from the A&D monitors was 1.9+/-2.8 mmHg and from the Welch Allyn monitors was 0.7+/-2.4 mmHg. No individual measurement showed a bias greater than 10 mmHg. A bias of greater than 5 mmHg was present in 28 out of 150 measurements for the A&D monitor and 10 out of 150 measurements for the Welch Allyn monitor. These results are comparable with ratings achieved by the instruments when tested previously according to the British Hypertension Society protocol, but testing with a simulator allowed assessment of aspects of performance which were not included in the British Hypertension Society protocol.


Subject(s)
Blood Pressure Determination/instrumentation , Blood Pressure Monitors , Blood Pressure , Computer Simulation , Artifacts , Blood Pressure/physiology , Blood Pressure Monitors/standards , Calibration , Equipment Design , Heart Rate/physiology , Humans , Quality Control , Reproducibility of Results
2.
Curr Med Chem ; 11(6): 747-53, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15032728

ABSTRACT

We have developed a series of 4-thiophenoxy-N-(3,4,5-trialkoxyphenyl) pyrimidine-2-amines as potent and selective inhibitors of p56lck tyrosine kinase activity. In particular, the most potent inhibitor shows cellular activity in T-cell receptor (TCR) stimulated models of cytokine release, which suggests an immunomodulatory role for this class of inhibitor.


Subject(s)
Adjuvants, Immunologic/pharmacology , Amines/pharmacology , Enzyme Inhibitors/pharmacology , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/antagonists & inhibitors , Pyrimidines/pharmacology , T-Lymphocytes/drug effects , Adjuvants, Immunologic/chemistry , Amines/chemistry , Binding, Competitive , Cells, Cultured , Enzyme Inhibitors/chemistry , Humans , Interleukin-2/immunology , Models, Molecular , Molecular Structure , Pyrimidines/chemistry , Structure-Activity Relationship , T-Lymphocytes/enzymology , T-Lymphocytes/immunology , Tumor Necrosis Factor-alpha/immunology
3.
Immunity ; 13(4): 433-42, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11070162

ABSTRACT

Immunoglobulin light chain (LC) normally is a soluble, secreted protein, but some LC assemble into ordered fibrils whose deposition in tissues results in amyloidosis and organ failure. Here we reconstitute fibril formation in vitro and show that preformed fibrils can nucleate polymerization of soluble LC. This prion-like behavior has important physiological implications, since somatic mutations generate multiple related LC sequences. Furthermore, we demonstrate that fibril formation in vitro and aggregation of whole LC within cells are inhibited by BiP and by a synthetic peptide that is identical to a major LC binding site for BiP. We propose that LC form fibrils via an interprotein loop swap and that the underlying conformational change should be amenable to drug therapy.


Subject(s)
Amyloid/antagonists & inhibitors , Amyloid/metabolism , Carrier Proteins/physiology , Heat-Shock Proteins , Immunoglobulin Light Chains/metabolism , Molecular Chaperones/physiology , Peptide Fragments/physiology , Amino Acid Sequence , Amino Acid Substitution/genetics , Amyloid/biosynthesis , Amyloid/genetics , Amyloidosis/genetics , Amyloidosis/immunology , Animals , COS Cells , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Carrier Proteins/metabolism , Endoplasmic Reticulum Chaperone BiP , Humans , Immunoglobulin Light Chains/genetics , Immunoglobulin Light Chains/physiology , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/metabolism , Immunoglobulin Variable Region/physiology , Mice , Microfibrils/metabolism , Molecular Chaperones/biosynthesis , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Molecular Sequence Data , Muscle, Smooth/metabolism , Mutagenesis, Site-Directed , Oligopeptides/metabolism , Oligopeptides/physiology , Peptide Fragments/metabolism , Solubility
4.
Clin J Sport Med ; 5(4): 236-40, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7496848

ABSTRACT

While there have been numerous reports in the literature of accidents in equestrian sports, no comprehensive study has been conducted to ascertain the nature and incidence of injuries incurred by professional horse-racing jockeys. A survey was conducted to determine the types of injuries to jockeys and racing-related health concerns, including weight reduction methods. The questionnaire was completed by 706 professional jockeys actively competing at United States racetracks between July and October 1990 about injuries they had sustained in their careers. More than 1,700 injuries were reported. Fractures (n = 1,113) accounted for 64% of the total. The most common cause of injury was becoming unseated, followed by the horse falling. Relationships between characteristics of jockeys and injuries were evaluated. There were significant numbers of serious injuries with prolonged periods of not riding. Recommendations for improving jockey safety are made.


Subject(s)
Athletic Injuries/epidemiology , Absenteeism , Accidents, Occupational/prevention & control , Accidents, Occupational/statistics & numerical data , Adult , Animals , Ankle Injuries/epidemiology , Arm Injuries/epidemiology , Athletic Injuries/classification , Athletic Injuries/prevention & control , Female , Foot Injuries/epidemiology , Fractures, Bone/epidemiology , Fractures, Bone/prevention & control , Health , Horses , Humans , Incidence , Leg Injuries/epidemiology , Male , Retrospective Studies , Risk Factors , Safety , Shoulder Injuries , Sports , Surveys and Questionnaires , United States/epidemiology , Weight Loss
5.
Nurs Manage ; 26(7): 32A, 32D-32F, 32H, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7603670

ABSTRACT

Health-care managers have a responsibility to create harmony within the workforce, increasingly a culturally diverse group. Suggestions offered by the literature for actions a manager can take to deal effectively with cultural diversity may not agree with employee perspectives on this issue. This article introduces a quasi-experimental evaluation method that may be used as introductory work for research in multicultural-workfoce management. This major challenge for health care in the next decade is second in importance only to health-care reform.


Subject(s)
Cultural Characteristics , Interprofessional Relations , Nursing, Supervisory/organization & administration , Personnel Management/methods , Cooperative Behavior , Female , Humans , Male
6.
Br J Educ Psychol ; 63 ( Pt 1): 88-95, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8466835

ABSTRACT

In this within-subjects design field experiment children's behaviour in the playground was charted as a function of gender and time in the classroom immediately preceding playtime. Playground behaviour was also related to post-recess classroom behaviour. Twenty-three 9-year-old children were observed for 14 weeks. Classroom behaviour (i.e., task relevant behaviour on standardised seat work immediately before and after playtime) and playground behaviour (i.e., social and non-social exercise and sedentary behaviour) were observed. Time in classroom before playtime was manipulated so that there was a shorter and a longer confinement period. Results indicated that children were less attentive to seat work as a function of time and that longer confinement resulted in more exercise for boys and more social sedentary behaviour for girls. Social behaviour at playtime and post-playtime attention to seat work were significantly related. Results are discussed in terms of Novelty Theory.


Subject(s)
Attention , Child Behavior , Play and Playthings , Social Environment , Child , Female , Gender Identity , Humans , Male , Motor Activity , Social Behavior
7.
J Med Chem ; 36(1): 21-9, 1993 Jan 08.
Article in English | MEDLINE | ID: mdl-8421286

ABSTRACT

The protein kinase inhibitor staurosporine has been used to design a series of selective bisindolylmaleimide inhibitors of protein kinase C (PKC). Guided by molecular graphics, conformational restriction of the cationic side chain has led to ATP competitive inhibitors of improved potency and selectivity. Two compounds have been further evaluated and were shown to inhibit PKC of human origin and prevent T-cell activation in a human allogeneic mixed lymphocyte reaction. One of these compounds was orally absorbed in mice and antagonized a phorbol ester induced paw edema in a dose-dependent manner. This compound also selectively inhibited the secondary T-cell mediated response in a developing adjuvant arthritis model in rats and provides evidence for the potential use of PKC inhibitors as therapeutic immunomodulators.


Subject(s)
Maleimides/chemical synthesis , Protein Kinase C/antagonists & inhibitors , Alkaloids/pharmacology , Animals , Humans , Maleimides/pharmacology , Mice , Models, Molecular , Molecular Conformation , Rabbits , Rats , Staurosporine , Stereoisomerism , Structure-Activity Relationship
8.
Agents Actions ; 37(1-2): 85-9, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1456183

ABSTRACT

The protein kinase C family of enzymes is thought to be important in mediating signal transduction. Ro 31-8830 is a novel, potent inhibitor of protein kinase C, derived from the non-selective protein kinase inhibitor staurosporine. In this paper we demonstrate the selectivity of Ro 31-8830 for protein kinase C over other protein kinases and its ability to inhibit protein kinase-C-mediated events in platelets and lymphocytes. In addition, we describe a novel system for the in vivo evaluation of inhibitors of protein kinase C, and we demonstrate the oral anti-inflammatory activity of Ro 31-8830. This finding has implications for the treatment of inflammatory disorders in the clinic.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Indoles/pharmacology , Maleimides/pharmacology , Protein Kinase C/antagonists & inhibitors , Administration, Oral , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Blood Platelets/drug effects , Blood Platelets/enzymology , CD3 Complex/drug effects , Cattle , Down-Regulation , Edema/drug therapy , Female , Humans , In Vitro Techniques , Indoles/administration & dosage , Male , Maleimides/administration & dosage , Mice , Phosphorylase Kinase/antagonists & inhibitors , Rabbits , Rats , T-Lymphocytes/drug effects , T-Lymphocytes/immunology
10.
J Med Chem ; 35(6): 994-1001, 1992 Mar 20.
Article in English | MEDLINE | ID: mdl-1552513

ABSTRACT

A hypothetical mode of inhibition of protein kinase C (PKC) by the natural product staurosporine has been used as a basis for the design of substituted bisindolylmaleimides with improved potency over the parent compound. Structure-activity relationships were consistent with the interaction of a cationic group in the inhibitor with a carboxylate group in the enzyme, and the most potent compound had a Ki of 3 nM. The inhibitors were competitive with ATP but inhibited cAMP-dependent protein kinase (PKA) only at much higher concentrations despite the extensive sequence homology between the ATP-binding regions of PKA and PKC. Three compounds were evaluated further and found to inhibit a human allogeneic mixed lymphocyte reaction pointing to the potential utility of PKC inhibitors in immunosuppressive therapy. One of these compounds was orally absorbed in the rat and represents an attractive lead in the development of PKC inhibitors as drugs.


Subject(s)
Maleimides/chemical synthesis , Protein Kinase C/antagonists & inhibitors , Animals , Cattle , Female , Humans , Maleimides/chemistry , Maleimides/pharmacology , Models, Molecular , Rats , Structure-Activity Relationship
11.
J Med Chem ; 35(1): 177-84, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1732526

ABSTRACT

The design and synthesis of a series of novel inhibitors of protein kinase C (PKC) is described. These 2,3-bisarylmaleimides were derived from the structural lead provided by the indolocarbazoles, staurosporine and K252a. Optimum activity required the imide NH, both carbonyl groups, and the olefinic bond of the maleimide ring. 2,3-Bisindolylmaleimides were the most active, and the potency of these was improved by a chloro substituent at the 5-position of one indole ring (compound 28, IC50 0.11 microM). In a series of (phenylindolyl)maleimides, nitro compound 74 was most active (IC50 0.67 microM). Naphthalene 19 and benzothiophene 21 showed greater than 100-fold selectivity for inhibition of PKC over the closely related cAMP-dependent protein kinase (PKA).


Subject(s)
Carbazoles/chemical synthesis , Indoles/chemical synthesis , Maleimides/chemical synthesis , Protein Kinase Inhibitors , Animals , Binding Sites , Carbazoles/chemistry , Carbazoles/pharmacology , Cattle , Indoles/chemistry , Indoles/pharmacology , Maleimides/chemistry , Maleimides/pharmacology , Rats , Structure-Activity Relationship
12.
FEBS Lett ; 293(1-2): 169-72, 1991 Nov 18.
Article in English | MEDLINE | ID: mdl-1660001

ABSTRACT

A novel, bis-indolylmaleimide, Ro 31-8425, bearing a conformationally restricted side chain, inhibits protein kinase C isolated from rat brain and human neutrophils with a high degree of selectivity over cAMP-dependent kinase and Ca2+/calmodulin-dependent kinase. It also inhibits phorbol ester-induced intracellular events known to be mediated by protein kinase C (p47 phosphorylation in intact platelets, CD3 and CD4 down-regulation in T-cells). Ro 31-8425 inhibited superoxide generation in human neutrophils activated by both receptor stimuli (formyl-methionyl-leucylphenylalanine, opsonized zymosan, IgG and heat aggregated IgG) and post-receptor stimuli (1,2-dioctanoylglycerol and fluoride). The compound also blocked antigen driven, but not IL-2 induced, T-cell proliferation. These results support a central role for protein kinase C in the activation of the respiratory burst and antigen-driven T-cell proliferation.


Subject(s)
Indoles/pharmacology , Maleimides/pharmacology , Neutrophils/drug effects , Protein Kinase C/chemistry , Receptors, Cell Surface/drug effects , Superoxides/antagonists & inhibitors , Animals , Brain/enzymology , Cattle , Humans , Neutrophils/enzymology , Neutrophils/metabolism , Protein Conformation , Protein Kinase C/antagonists & inhibitors , Rabbits , Rats , Receptors, Cell Surface/metabolism , Respiratory Burst/drug effects , Solubility , Superoxides/blood
13.
Agents Actions ; 32(3-4): 188-93, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1650519

ABSTRACT

H7 has been described as a potent inhibitor of protein kinase C (PKC) and has been widely used to investigate the regulatory role of this enzyme in intact cell systems. In this comparative study between H7 and the microbial alkaloid, staurosporine, we found that the former inhibited rat brain PKC and cAMP dependent protein kinase with IC50 values of 18 and 16 microM respectively whereas the latter was a much more potent inhibitor of both kinases with IC50 values of 9.5 nM and 42 nM respectively. H7, at concentrations up to 100 microM, failed to block cellular events induced by phorbol esters, agents which specifically stimulate PKC, yet was a potent inhibitor of IL-2 induced T cell proliferation with an IC50 value of 19 microM. In contrast, staurosporine was a potent inhibitor of both phorbol ester induced p47 phosphorylation in platelet (I50 value = 540 nM) and also CD3 and CD4 down-regulation in T cells (I50 values 200 nM and 50 nM respectively). Staurosporine was also a potent inhibitor of IL-2 induced T cell proliferation I50 value = 9 nM). These results provide a strong argument against the use of H7 to probe for PKC involvement in cellular processes.


Subject(s)
Isoquinolines/pharmacology , Piperazines/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein Kinase Inhibitors , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine , Alkaloids/pharmacology , Animals , Brain/enzymology , CD4 Antigens/metabolism , Cyclic AMP/pharmacology , Down-Regulation , Interleukin-2/pharmacology , Lymphocyte Activation , Mice , Molecular Weight , Phorbol 12,13-Dibutyrate/pharmacology , Phosphoproteins/metabolism , Phosphorylation , Rats , Receptors, Antigen, T-Cell/metabolism , Staurosporine , T-Lymphocytes/immunology , Tetradecanoylphorbol Acetate/pharmacology
14.
Drugs Exp Clin Res ; 17(8): 389-93, 1991.
Article in English | MEDLINE | ID: mdl-1822831

ABSTRACT

Clarification of the precise role of protein kinase C (PKC) in cellular functional responses has been hampered by a lack of potent, selective inhibitors. The structural lead provided by staurosporine, a potent but non-selective protein kinase (PK) inhibitor, was used to derive a series of bis(indolyl)maleimides of which the most potent, Ro 31-8425 (I50: PKC = 8 nM) showed 350-fold selectivity for PKC over cAMP-dependent protein kinase. Ro 31-8425 antagonised cellular processes triggered by phorbol esters (potent, specific PKC activators) and inhibited the allogeneic mixed lymphocyte reaction, suggesting a role for PKC in T-cell activation. Methylation of the primary amine in Ro 31-8425 produced an analogue. Ro 31-8830 which, when administered orally, produced a dose-dependent inhibition of a phorbol ester-induced paw oedema in mice (minimum effective dose = 15 mg/kg). Ro 31-8830 also selectively inhibited the secondary inflammation in a developing adjuvant arthritis model in the rat. The results presented here suggest that these selective inhibitors of PKC may have therapeutic value in the treatment of T-cell-mediated autoimmune diseases.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Protein Kinase C/antagonists & inhibitors , Administration, Oral , Animals , Anti-Inflammatory Agents , Arthritis, Experimental/drug therapy , Female , Indoles/pharmacology , Male , Maleimides/pharmacology , Mice , Phorbol Esters/pharmacology , Rats
15.
Biochem Biophys Res Commun ; 171(1): 148-54, 1990 Aug 31.
Article in English | MEDLINE | ID: mdl-2393389

ABSTRACT

The inhibition of phosphorylase kinase by a number of protein kinase inhibitors was examined. Both K252a and staurosporine are potent inhibitors of phosphorylase kinase with IC50 values of 1.7 nM and 0.5 nM respectively. K252a shows a 300-fold selectivity for this enzyme over protein kinase C whereas staurosporine shows only a 20-fold selectivity for phosphorylase kinase. In contrast, the Roche bis-indolyl maleimides inhibit phosphorylase kinase with IC50 values of approximately 1 microM and are highly selective for protein kinase C.


Subject(s)
Carbazoles/pharmacology , Phosphorylase Kinase/antagonists & inhibitors , Protein Kinase Inhibitors , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine , Alkaloids/pharmacology , Animals , In Vitro Techniques , Indole Alkaloids , Isoquinolines/pharmacology , Kinetics , Muscles/enzymology , Piperazines/pharmacology , Rabbits , Staurosporine , Structure-Activity Relationship
16.
FEBS Lett ; 259(1): 61-3, 1989 Dec 18.
Article in English | MEDLINE | ID: mdl-2532156

ABSTRACT

A series of potent, selective inhibitors of protein kinase C has been derived from the structural lead provided by the microbial broth products, staurosporine and K252a. Our inhibitors block PCK in intact cells (platelets and T cells), and prevent the proliferation of mononuclear cells in response to interleukin 2 (IL2).


Subject(s)
Protein Kinase C/antagonists & inhibitors , Alkaloids/pharmacology , Animals , Antigens, Differentiation, T-Lymphocyte/metabolism , Blood Platelets/metabolism , Brain/enzymology , CD3 Complex , Carbazoles/pharmacology , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Imides , Indole Alkaloids , Protein Kinase Inhibitors , Rats , Receptors, Antigen, T-Cell/metabolism , Staurosporine , Structure-Activity Relationship
17.
Biochim Biophys Acta ; 997(1-2): 9-14, 1989 Jul 27.
Article in English | MEDLINE | ID: mdl-2752056

ABSTRACT

A number of long-chain amines and naphthylamine sulfonates have been studied for their ability to inhibit bovine pancreatic phospholipase A2 (PLA2) and to protect PLA2 against alkylation of the active site histidine by p-bromophenacyl bromide. Their areas of interaction on the enzyme were further delineated using observations of chemical shift changes of assigned aromatic signals in the 1H-NMR spectrum of PLA2, while the bound conformations of two amine inhibitors were revealed using transferred nuclear Overhauser effects. The alkyl amines bind rather non-specifically on the surface of the enzyme, over the active site cleft and the interface recognition site.


Subject(s)
Ligands/metabolism , Phospholipases A/antagonists & inhibitors , Phospholipases/antagonists & inhibitors , Amines/metabolism , Amines/pharmacology , Animals , Cattle , Magnetic Resonance Spectroscopy , Models, Molecular , Naphthalenesulfonates/metabolism , Naphthalenesulfonates/pharmacology , Pancreas/enzymology , Phospholipases A/metabolism , Phospholipases A2
19.
Int J Biomed Comput ; 17(1): 27-30, 1985 Jul.
Article in English | MEDLINE | ID: mdl-3840456

ABSTRACT

Collection of data is often difficult in medical and nursing applications of computers. A system has been developed using an inexpensive light pen to enter most of the required information. This method of data entry has proved to be acceptable to medical and nursing staff in clinical situations. The software places light blocks adjacent to a list of items available for selection. When the pen is applied to a light block, the item is selected with visual and audible confirmation being given. Corrections may be made by re-applying the pen to the light block.


Subject(s)
Computers , Data Display , Microcomputers , Software
20.
Anaesthesia ; 37(2): 201-3, 1982 Feb.
Article in English | MEDLINE | ID: mdl-6952774

ABSTRACT

Investigations using recommended gauging tools have shown that many tapered connectors on breathing systems do not meet the relevant standard. It would be important to improve dimensional tolerances so that better interchangeability is achieved. This improvement may make it unnecessary to employ 'anti-disconnexion' fittings.


Subject(s)
Ventilators, Mechanical , Adult , Equipment Design , Equipment Safety , Humans
SELECTION OF CITATIONS
SEARCH DETAIL